Drug dosage individualization based on a random-effects linear lodel


Por: Diaz, Francisco J., Cogollo, Myladis R., Spina, Edoardo, Santoro, Vincenza, Rendon, Diego M., de Leon, Jose

Publicada: 1 ene 2012
Resumen:
This article investigates drug dosage individualization when the patient population can be described with a random-effects linear model of a continuous pharmacokinetic or pharmacodynamic response. Specifically, we show through both decision-theoretic arguments and simulations that a published clinical algorithm may produce better individualized dosages than some traditional methods of therapeutic drug monitoring. Since empirical evidence suggests that the linear model may adequately describe drugs and patient populations, and linear models are easier to handle than the nonlinear models traditionally used in population pharmacokinetics, our results highlight the potential applicability of linear mixed models to dosage computations and personalized medicine. Copyright © Taylor & Francis Group, LLC.

Filiaciones:
Diaz, Francisco J.:
 Univ Kansas, Med Ctr, Dept Biostat, Kansas City, KS 66160 USA

Cogollo, Myladis R.:
 Univ EAFIT, Dept Basic Sci, Medellin, Colombia

Spina, Edoardo:
 Univ Messina, Pharmacol Sect, Dept Clin & Expt Med & Pharmacol, Messina, Italy Univ Messina Policlin, IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy

Santoro, Vincenza:
 Univ Messina, Pharmacol Sect, Dept Clin & Expt Med & Pharmacol, Messina, Italy Univ Messina Policlin, IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy

Rendon, Diego M.:
 Financial Anal Unit Secretaria Hacienda, Medellin, Colombia

de Leon, Jose:
 Mental Hlth Res Ctr, Lexington, KY USA
ISSN: 10543406
Editorial
TAYLOR & FRANCIS INC, 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
Tipo de documento: Article
Volumen: 22 Número: 3
Páginas: 463-484
WOS Id: 000304678600003
ID de PubMed: 22416835
imagen

MÉTRICAS